Clinical evaluation of large volume subcutaneous injection tissue effects, pain, and acceptability in healthy adults

• Published in: Clinical and translational science Vol. 15; no. 1; pp. 92 - 104
• Main Authors: Woodley, Wendy D., Morel, Didier R., Sutter, Diane E., Pettis, Ronald J., Bolick, Natasha G.
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.01.2022; John Wiley and Sons Inc; Wiley
• Subjects: Abdomen; Adolescent; Adult; Aged; Chronic illnesses; Cross-Over Studies; Disease; Equipment Design; Erythema; Feasibility Studies; Female; Humans; Hyaluronic acid; Immune system; Immunotherapy; Injection; Injections, Subcutaneous - adverse effects; Injections, Subcutaneous - methods; Male; Medical equipment; Middle Aged; Pain; Pain - etiology; Physiology; Skin; Viscosity; Young Adult; France
• ISSN: 1752-8054; 1752-8062; 1752-8062
• DOI: 10.1111/cts.13109

Determining feasibility and tolerability of large volume viscous subcutaneous injection may enable optimized, intuitive delivery system design. A translational early feasibility clinical study examined large volume subcutaneous injection viability, tolerability, acceptability, tissue effects and depot location for ~1, 8, and 20 cP injections at volumes up to 10 ml in the abdomen and 5 ml in the thigh in 32 healthy adult subjects. A commercial syringe pump system delivered 192 randomized, constant rate (20 µl/s) injections (6/subject) with in‐line injection pressure captured versus time. Deposition location was qualified via ultrasound. Tissue effects and pain tolerability were monitored through 2 hours post‐injection with corresponding Likert acceptability questionnaires administered through 72 hours. All injection conditions were feasible and well‐tolerated with ≥79.3% favorable subject responses for injection site appearance and sensation immediately post‐injection, increasing to ≥96.8% at 24 hours. Mean subject pain measured via 100 mm visual analog scale increased at needle insertion (6.9 mm, SD 10.8), peaked during injection (26.9 mm, SD 21.7) and diminished within 10 minutes post‐removal (1.9 mm, SD 4.2). Immediate injection site wheal (90.9%) and erythema (92.6%) formation was observed with progressive although incomplete resolution through 2 hours (44.6% and 11.4% remaining, respectively). Wheal resolution occurred more rapidly at lower viscosities. Most subjects (64.5%) had no preference between abdomen and thigh. Correlations between tissue effects, injection pressure and pain were weak (Pearson’s rho ± 0–0.4). The large volume injections tested, 1–20 cP viscosities up to 10 ml in the abdomen and 5 ml in the thigh, are feasible with good subject acceptability and rapid resolution of tissue effects and pain.